Updates on Cell & Gene Therapy | Sarawak Society For Cell & Gene Therapy Research (SSCTR)

Illustration of pharmaceutical collaboration focused on liver disease therapy, showing a symbolic liver and molecular targets representing GSK’s acquisition deal

GSK Acquires Efruxifermin for $2B, Targeting MASH and Liver Fibrosis

Published on Spencer Knight via LinkedIn GSK is acquiring efruxifermin alfa from Boston Pharmaceuticals for up to $2 billion, including...

CGT Milestones

Jun 17

Illustration of a newborn receiving supportive care for brain injury, symbolizing regenerative therapy for hypoxic birth-related conditions in a neonatal unit

HAON Life Sciences Secures €10.7M to Advance Allogeneic Cell Therapy for Infant Brain Injury

Published on Spencer Knight via LinkedIn HAON Life Sciences, a Dublin-based biotech startup, has received €10.7 million from Ireland’s...

CGT Milestones

Jun 17

Portrait of a young woman smiling during recovery in a hospital room after CRISPR therapy for late-stage colon cancer

CRISPR Eliminates Stage 4 Colon Cancer in Breakthrough First-in-Human Trial

Published on Spencer Knight via LinkedIn Emma Dimey was diagnosed with stage 4 colorectal cancer at just 23. After 11 years of failed...

CGT Milestones

Jun 17

Diagram of a human body silhouette labeled with cancer-associated genes sized by mutation frequency across different organ systems

Cancer Gene Map Highlights Top Mutations Like P53, PI3K, and BRAF

Published on Spencer Knight via LinkedIn This unique visualization illustrates the prevalence of gene mutations across different parts of...

Educational Insights

Jun 17

Portrait of a young boy in a hospital bed recovering from gene therapy for a rare immune condition, smiling brightly with supportive surroundings

Gene Therapy Saves 4-Year-Old with Rare Immune Disorder Once Considered Fatal

Published on Spencer Knight via LinkedIn Eisa Hussain was diagnosed as an infant with leukocyte adhesion deficiency type 1 (LAD-1), a...

CGT Milestones

Jun 17

Concept image of a biotech acquisition with RNA molecular symbols and kidney treatment themes representing Novartis and Regulus deal

Novartis to Acquire Regulus for $1.7B, Advancing MicroRNA Therapies

Published on Spencer Knight via LinkedIn Novartis is acquiring Regulus Therapeutics for up to $1.7 billion to expand its position in...

CGT Milestones

Jun 17

Illustration of a pediatric patient receiving a gene-corrected skin graft for a rare genetic skin condition in a modern clinical setting

Abeona’s ZEVASKYN™ Becomes First Cell-Based Gene Therapy Approved for RDEB

Published on Spencer Knight via LinkedIn The FDA has approved ZEVASKYN™, the first-ever autologous cell-based gene therapy for patients...

CGT Milestones

Jun 17

Image of a clean and modern biotech facility on a sunny day, symbolizing successful commercialization of gene therapy products

Ferring’s ADSTILADRIN Hits €70M in Year One, Validating Gene Therapy Market Growth

Published on Spencer Knight via LinkedIn Ferring Pharmaceuticals has emerged as a commercial frontrunner in gene therapy with the...

CGT Milestones

Jun 17

Portrait of a smiling woman in her late 50s at home with natural light, symbolizing recovery and renewed life after CAR-T therapy for lymphoma

From 2 Weeks to Cancer-Free: Lisa Noble’s Remarkable CAR-T Therapy Outcome

Published on Spencer Knight via LinkedIn Lisa Noble, 58, was given just two weeks to live after failing chemotherapy for B cell lymphoma....

CGT Milestones

Jun 17

Photo of a clinical researcher preparing a cancer vaccine in a sterile lab setting as part of a melanoma immunotherapy trial in the UK

10,000 Cancer Patients to Gain Fast-Track Access Through NHS Melanoma Vaccine Trial

Published on Spencer Knight via LinkedIn The NHS in England is fast-tracking a cancer vaccine trial for melanoma through its Cancer...

CGT Milestones

Jun 17

Illustration of a lipid nanoparticle delivering CAR mRNA to T cells for in vivo therapy, set in a clean lab environment with global clinical trial icons

Capstan Launches In Vivo CAR-T Trial Using LNP Technology for Oncology

Published on Spencer Knight via LinkedIn Capstan Therapeutics has entered Phase 1 trials with CPTX2309, an in vivo CAR-T candidate that...

CGT Milestones

Jun 17

Illustration of biotech salary report data showing earnings trends for scientific, clinical, and executive roles in the life sciences industry

2025 Salary Report Shows Rising Pay and Part-Time Leadership Trend in Biotech

Published on Spencer Knight via LinkedIn BioSpace’s 2025 Life Sciences Salary Report highlights key compensation benchmarks in biotech....

Educational Insights

Jun 17

Group photo of hospital clinicians celebrating CAR-T therapy success in a modern clinical corridor

Hospital Clínic-IDIBAPS Treats Over 500 Cancer Patients with Academic CAR-T Therapy

Published on Spencer Knight via LinkedIn Hospital Clínic Barcelona-IDIBAPS has become a European leader in academic CAR-T, treating over...

CGT Milestones

Jun 17

Futuristic illustration of neural cells receiving therapeutic stem cell input to calm epilepsy-related brain activity

Neurona Raises $102M to Advance Cell Therapy for Drug-Resistant Epilepsy

Published on Spencer Knight via LinkedIn Neurona Therapeutics has secured $102 million to push forward its cell therapy NRTX-1001, which...

CGT Milestones

Jun 17

Concept illustration showing a stylized human eye with DNA in the iris, representing gene therapy for inherited blindness

Atsena Raises $150M to Advance Gene Therapy for Inherited Blindness

Published on Spencer Knight via LinkedIn Atsena Therapeutics has secured an oversubscribed $150 million Series C round, led by Bain...

CGT Milestones

Jun 17

Stylized collage representing major biotech companies advancing gene editing with CRISPR tools, FDA designations, and clinical trial milestones

Gene Editing Sees Surge in Trials, Funding, and FDA Momentum Across Six Companies

Published on Spencer Knight via LinkedIn Multiple gene editing breakthroughs were announced in a single week, signaling strong momentum...

CGT Milestones

Jun 17

Infographic showing the CAR-T therapy workflow from blood collection to reinfusion of engineered T cells targeting cancer cells

Studies Show CAR-T Therapy Carries Extremely Low Secondary Cancer Risk

Published on Spencer Knight via LinkedIn Concerns about secondary cancers from CAR-T therapy may be overstated, according to new data. A...

Educational Insights

Jun 17

Photo of a baby peacefully recovering at home after gene therapy for OTC deficiency, showing calm and comfort in a natural setting

Gene Therapy Saves Baby with Rare Liver Disorder in World-First Trial

Published on Spencer Knight via LinkedIn A 14-month-old boy named Tomas, born with a life-threatening liver disorder called OTC...

CGT Milestones

Jun 17

Concept illustration showing biotech collaboration for in vivo cell therapy, featuring a syringe and engineered immune cells between two partners shaking hands

AstraZeneca Acquires EsoBiotec for $1B, Advancing In Vivo Cell Therapy

Published on Spencer Knight via LinkedIn AstraZeneca has acquired Belgian biotech EsoBiotec for $1 billion, including $425 million...

CGT Milestones

Jun 17

Illustration of two biotech headquarters side by side, representing the merger of BMS and 2seventy bio in a corporate cell therapy acquisition

Bristol Myers Squibb Acquires 2seventy bio for $286M, Strengthening Cell Therapy Portfolio

Published on Spencer Knight via LinkedIn Bristol Myers Squibb has acquired 2seventy bio in an all-cash deal worth $286 million, offering...

CGT Milestones

Jun 17

5 68 9

GSK Acquires Efruxifermin for $2B, Targeting MASH and Liver Fibrosis

HAON Life Sciences Secures €10.7M to Advance Allogeneic Cell Therapy for Infant Brain Injury

CRISPR Eliminates Stage 4 Colon Cancer in Breakthrough First-in-Human Trial

Cancer Gene Map Highlights Top Mutations Like P53, PI3K, and BRAF

Gene Therapy Saves 4-Year-Old with Rare Immune Disorder Once Considered Fatal

Novartis to Acquire Regulus for $1.7B, Advancing MicroRNA Therapies

Abeona’s ZEVASKYN™ Becomes First Cell-Based Gene Therapy Approved for RDEB

Ferring’s ADSTILADRIN Hits €70M in Year One, Validating Gene Therapy Market Growth

From 2 Weeks to Cancer-Free: Lisa Noble’s Remarkable CAR-T Therapy Outcome

10,000 Cancer Patients to Gain Fast-Track Access Through NHS Melanoma Vaccine Trial

Capstan Launches In Vivo CAR-T Trial Using LNP Technology for Oncology

2025 Salary Report Shows Rising Pay and Part-Time Leadership Trend in Biotech

Hospital Clínic-IDIBAPS Treats Over 500 Cancer Patients with Academic CAR-T Therapy

Neurona Raises $102M to Advance Cell Therapy for Drug-Resistant Epilepsy

Atsena Raises $150M to Advance Gene Therapy for Inherited Blindness

Gene Editing Sees Surge in Trials, Funding, and FDA Momentum Across Six Companies

Studies Show CAR-T Therapy Carries Extremely Low Secondary Cancer Risk

Gene Therapy Saves Baby with Rare Liver Disorder in World-First Trial

AstraZeneca Acquires EsoBiotec for $1B, Advancing In Vivo Cell Therapy

Bristol Myers Squibb Acquires 2seventy bio for $286M, Strengthening Cell Therapy Portfolio

Sarawak Society for Cell & Gene Therapy Research

Quick Links